The Alzheimer’s drug Donanemab slowed cognitive decline within the trial

New scientific trial information launched Posted by means of Eli Lilly on Wednesday introduced essentially the most promising result of any attainable remedy for Alzheimer’s illness thus far. In a randomized, double-blind, managed section III trial, the experimental drug dunanimab considerably slowed cognitive decline in sufferers in comparison to a placebo, with just about part … Read more